Design, preparation, and characterization of bovine papillomavirus chitosan-based nanoparticles as a prototype for a bovine papillomatosis vaccine

The bovine papillomavirus (BPV) is known to cause lesions in the epithelial tissue of cattle, which causes bovine papillomatoses. This disease is characterized by wart lesions in different body parts, causing losses in the animal value. Despite the economic impact, there are no effective vaccines available at this moment. The present study aims to develop a nanoformulated autogenous vaccine using the inactivated virus present in warts to control the diseases associated with BPV. To this end, papillomavirus was collected from infected bovines on a farm in Goiás, Brazil. The warts containing the viruses were macerated to obtain the inactivated viruses to be formulated within chitosan nanoparticles. The chitosan nanoparticles containing the inactivated viruses presented 330.7 nm in size, a polydispersity index of 0.41, and a positive Zeta potential of 38.2 mV. The association efficiency was 58.3%. The nanoparticles containing the inactivated virus were stable for up to 30 days and presented no hemolysis toxicity. This could be an interesting approach to develop a vaccine to protect bovines from BPV infection.

Authors

Institutions

Publication Details

Journal
Anais da Academia Brasileira de Ciências
Published
2025-01-01
DOI
https://doi.org/10.1590/0001-3765202520241155
Primary Topic
Milk Quality and Mastitis in Dairy Cows
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Design, preparation, and characterization of bovine papillomavirus chitosan-based nanoparticles as a prototype for a bovine papillomatosis vaccine

Carla Afonso da Silva Bitencourt Braga, André Corrêa Amaral, Raquel Brito
Anais da Academia Brasileira de Ciências
Milk Quality and Mastitis in Dairy Cows
article

Design, preparation, and characterization of bovine papillomavirus chitosan-based nanoparticles as a prototype for a bovine papillomatosis vaccine

Carla Afonso da Silva Bitencourt Braga, André Corrêa Amaral, Raquel Brito
article en

Abstract

The bovine papillomavirus (BPV) is known to cause lesions in the epithelial tissue of cattle, which causes bovine papillomatoses. This disease is characterized by wart lesions in different body parts, causing losses in the animal value. Despite the economic impact, there are no effective vaccines available at this moment. The present study aims to develop a nanoformulated autogenous vaccine using the inactivated virus present in warts to control the diseases associated with BPV. To this end, papillomavirus was collected from infected bovines on a farm in Goiás, Brazil. The warts containing the viruses were macerated to obtain the inactivated viruses to be formulated within chitosan nanoparticles. The chitosan nanoparticles containing the inactivated viruses presented 330.7 nm in size, a polydispersity index of 0.41, and a positive Zeta potential of 38.2 mV. The association efficiency was 58.3%. The nanoparticles containing the inactivated virus were stable for up to 30 days and presented no hemolysis toxicity. This could be an interesting approach to develop a vaccine to protect bovines from BPV infection.

Anais da Academia Brasileira de CiênciasVol. 97(1)
Universidade Federal de Goiás (BR)
Good health and well-being
Openalex Percentile: Top 93%
Milk Quality and Mastitis in Dairy Cows
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Design, preparation, and characterization of bovine papillomavirus chitosan-based nanoparticles as a prototype for a bovine papillomatosis vaccine — Carla Afonso da Silva Bitencourt Braga, André Corrêa Amaral, et al. · Anais da Academia Brasileira de Ciências (2025) | TGRS Research Map | TGRS